治疗耐药性的途径:骨髓微环境对多发性髓瘤细胞的保护作用
Kuntal Bhowmick1, Max von Suskil1, Omar S Al-Odat1
1Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA.
Heliyon
|July 18, 2024
概括
多发性骨髓瘤 (MM) 由于耐药性,仍然无法治愈,这在很大程度上是由骨髓微环境 (BMME) 推动的. 本综述探讨了BMME如何促进MM生存和治疗耐药性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 多发性髓瘤 (MM) 是骨髓 (BM) 中的一种血细胞恶性瘤.
- 尽管有新的治疗方法,但MM仍然是无法治愈的,原因是药物耐药性.
- 骨髓微环境 (BMME) 在很大程度上促进了MM的耐药性.
研究的目的:
- 审查BMME在多发性髓瘤中的作用.
- 阐明BMME如何影响MM生存和进展.
- 总结MM的治疗特异性耐药机制.
主要方法:
- 在多发性髓瘤中对骨髓微环境的文献综述.
- 分析BMME在髓瘤细胞中激活的通路.
- 识别对MM疗法的耐药性机制.
主要成果:
- BMME为髓瘤细胞提供生存和生长信号.
- BMME 组件诱导压力并激活促进MM进展的途径.
- 在BMME内部的特定机制有助于治疗耐药性.
结论:
- BMME是MM病原和治疗失败的关键因素.
- 准BMME可能为克服MM的耐药性提供新的策略.
- 了解BMME-骨髓瘤相互作用对于开发有效的MM疗法至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


